Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1

Wen Peng1, Chuan Zhang1, Jianing Peng2

  • 1The First School of Clinical Medicine, Nanjing Medical University, PR China, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, PR China.

Cancer Letters
|September 1, 2020
PubMed

Insights

Long non-coding RNA FAM84B (lnc-FAM84B-4) promotes colorectal cancer (CRC) by inhibiting DUSP1 expression. This lnc-FAM84B-4-hnRNPK-DUSP1 axis offers a potential therapeutic target for CRC treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The mitogen-activated protein kinase (MAPK) pathway is crucial in cancer development.
  • Dual-specificity MAPK phosphatases (MKPs/DUSPs) regulate MAPK activity but their role in colorectal cancer (CRC) is unclear.

Purpose of the Study:

  • To investigate the roles of lnc-FAM84B-4 and DUSP1 in the MAPK pathway and CRC.
  • To elucidate the regulatory mechanism of lnc-FAM84B-4 in CRC.

Main Methods:

  • Re-mining CRC microarray data to identify upregulated lnc-FAM84B-4.
  • In vitro and in vivo functional assays.
  • RNA-Seq, RNA pull-down, and RIP assays to determine molecular mechanisms.

Main Results:

  • lnc-FAM84B-4 was upregulated in CRC and restrains DUSP1 expression, thereby regulating the MAPK pathway.
  • hnRNPK was identified as a binding partner of lnc-FAM84B-4, mediating DUSP1 expression.
  • The lnc-FAM84B-4-hnRNPK-DUSP1 axis plays a significant role in CRC development.

Conclusions:

  • lnc-FAM84B-4 promotes CRC by inhibiting DUSP1 expression via the hnRNPK-dependent mechanism.
  • The identified axis represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K